The Food and Drug Administration (FDA) recently issued “marketing denial orders” (MDOs) for the myblu vaping device and several of its tobacco-flavoured pods.
Previous articles have reported that the FDA has been reckless in issuing MDOs without presenting relevant evidence to back up its decisions.
The first batch of rejections came in early August 2021, when the FDA announced that it would not even review the 4.5 million applications from the same company, JD Nova, on grounds that they did not include an adequate Environmental Assessment.
At the end of the same month, the agency issued MDOs, for applications related to flavoured vaping products (55,000 from one company and 800 from another), based on the excuse that these failed to provide “product-specific scientific evidence to demonstrate enough of a benefit to adult smokers that would overcome the risk posed to youth.”
Diane Caruana – VapingPost – 2022-04-27.